• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Operational Challenges With Early Identification in Alzheimer Disease

Opinion
Video

Panelists discuss how APPs mitigate operational barriers that delay Alzheimer detection and diagnosis.

Panelists discuss how clinical, administrative, and systemic barriers hinder early Alzheimer identification. Limitations include inadequate screening resources, long wait times for neurology consultations, and the absence of standardized diagnostic pathways across care settings.

Panelists discuss how advanced practice providers (APPs) can help address these issues by implementing efficient workflows, establishing referral protocols, and coordinating multidisciplinary evaluations. They also advocate for better use of technology, including electronic health-record prompts and telehealth tools, to expand reach and reduce diagnostic lag.

Panelists discuss how solutions depend on organizational commitment to supporting early detection programs and empowering APPs with autonomy and training. By leading operational improvements, APPs reduce inefficiencies that contribute to delayed diagnosis and suboptimal care.

Related Videos
6 experts are featured in this series.
6 experts are featured in this series.
6 experts are featured in this series.
6 experts are featured in this series.
6 experts are featured in this series.
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.